Literature DB >> 18830226

Personalized therapeutics: HIV treatment in adolescents.

N Y Rakhmanina1, E V Capparelli, J N van den Anker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18830226      PMCID： PMC2803031          DOI： 10.1038/clpt.2008.187

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  21 in total

1.  Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism.

Authors:  Akihiko Saitoh; Courtney V Fletcher; Richard Brundage; Carmelita Alvero; Terrence Fenton; Karen Hsia; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

2.  Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Authors:  Paige L Williams; Deborah Storm; Grace Montepiedra; Sharon Nichols; Betsy Kammerer; Patricia A Sirois; John Farley; Kathleen Malee
Journal:  Pediatrics       Date:  2006-11-13       Impact factor: 7.124

3.  Hormonal, auxological and clinical follow-up in children with connatal HIV infection. Personal records.

Authors:  L Titone; M C Maggio; P Di Carlo; A Romano; S Teresi; E Guicciardino; M Saitta; A Liotta
Journal:  Minerva Pediatr       Date:  2006-10       Impact factor: 1.312

4.  Growth and normal puberty.

Authors:  V Abbassi
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

5.  Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors.

Authors:  Brian L Robbins; Edmund V Capparelli; Ellen G Chadwick; Ram Yogev; Leslie Serchuck; Carol Worrell; Mary Elizabeth Smith; Carmelita Alvero; Terence Fenton; Barbara Heckman; Stephen I Pelton; Grace Aldrovandi; William Borkowsky; John Rodman; Peter L Havens
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

6.  Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.

Authors:  Jennifer J Kiser; Courtney V Fletcher; Patricia M Flynn; Coleen K Cunningham; Craig M Wilson; Bill G Kapogiannis; Hanna Major-Wilson; Rolando M Viani; Nancy X Liu; Larry R Muenz; D Robert Harris; Peter L Havens
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

7.  Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.

Authors:  Patricia M Flynn; John Rodman; Jane C Lindsey; Brian Robbins; Edmund Capparelli; Katherine M Knapp; Jose F Rodriguez; James McNamara; Leslie Serchuck; Barbara Heckman; Jaime Martinez
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

Review 8.  Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.

Authors:  Jane M Simoni; Arianna Montgomery; Erin Martin; Michelle New; Penelope A Demas; Sohail Rana
Journal:  Pediatrics       Date:  2007-05-28       Impact factor: 7.124

9.  Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms.

Authors:  Samuel Fanta; Mikko Niemi; Siv Jönsson; Mats O Karlsson; Christer Holmberg; Pertti J Neuvonen; Kalle Hoppu; Janne T Backman
Journal:  Pharmacogenet Genomics       Date:  2008-02       Impact factor: 2.089

10.  Increasing antiretroviral drug access for children with HIV infection.

Authors:  Peter L Havens; Diana M Gibb
Journal:  Pediatrics       Date:  2007-04       Impact factor: 7.124
View more
  6 in total

Review 1.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

2.  Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Authors:  Natella Y Rakhmanina; John N van den Anker; Steven J Soldin; Ron H van Schaik; Nick Mordwinkin; Michael N Neely
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

3.  Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.

Authors:  Brookie M Best; Edmund V Capparelli; Huy Diep; Steven S Rossi; Michael J Farrell; Elaine Williams; Grace Lee; John N van den Anker; Natella Rakhmanina
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-01       Impact factor: 3.731

4.  High dose of darunavir in treatment-experienced HIV-infected adolescent results in virologic suppression and improved CD4 cell count.

Authors:  Natella Y Rakhmanina; Michael N Neely; Edmund V Capparelli
Journal:  Ther Drug Monit       Date:  2012-06       Impact factor: 3.681

Review 5.  Pharmacotherapy of pediatric HIV infection.

Authors:  Natella Rakhmanina; B Ryan Phelps
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

6.  Global HIV/AIDS Clinical and Translational Pharmacology.

Authors:  Gene D Morse; Gary Maartens; Charles Chiedza Maponga; Qing Ma
Journal:  AIDS Res Treat       Date:  2012-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.